See your results below for :
Brixadi 1ML of 128MG/0.36ML : Syringe - 1

Brixadi Coupons & Prices

What is Brixadi ?

Brixadi (buprenorphine) is a once-weekly or once-monthly extended-release injectable medication approved for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a transmucosal buprenorphine-containing product. It functions primarily as a partial agonist at opioid receptors, helping to prevent withdrawal symptoms and reduce opioid cravings. Brixadi is intended to be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.

Brixadi

bue-pre-NOR-feen

Consumer Forms
Injectable

Consumer Routes
By injection

Therapeutic Classes
Anesthetic Adjunct , Analgesic , Opioid Dependency

  • Drowsiness
  • Mild nausea, vomiting, constipation, or diarrhea
  • Mild nausea
  • Pain, itching, burning, swelling, or lump under your skin where the needle is placed
  • Pain, itching, burning, swelling, or lump under your skin where the needle is placed or shot given
  • Changes in skin color, dark freckles, cold feeling, tiredness, weight loss
  • Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
  • Anxiety, restlessness, fever, muscle spasms, twitching, nausea, vomiting, diarrhea, seeing or hearing things that are not there
  • Dark urine or pale stools, loss of appetite, yellow skin or eyes
  • Blue lips, fingernails, or skin
  • Extreme dizziness or weakness, shallow breathing, slow or uneven heartbeat, sweating, cold or clammy skin, seizures
  • Fast, slow, or pounding heartbeat
  • Severe constipation, stomach pain
  • Lightheadedness, dizziness, fainting
  • Shaking, trembling, hunger, confusion
  • Worsening of pain, increased sensitivity to pain
  • Risk of opioid addiction, abuse, and misuse, which can lead to overdose and death
  • Serious, life-threatening, or fatal respiratory depression may occur
  • Accidental ingestion can result in a fatal overdose of buprenorphine
  • Neonatal opioid withdrawal syndrome may occur in newborn infants of mothers who are treated with buprenorphine during pregnancy
  • Concomitant use with benzodiazepines or other CNS depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death

Don't Miss Out On Savings!


Rx.com does not warrant the accuracy of the information on this website. All information on this site is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of a drug is safe, appropriate, or effective for you. Consult your healthcare professional before using any drug. All logos, brand names and trademarks on this website are the property of their respective owners. Rx.com is not endorsed or affiliated with any brands represented on this website."

Pharmacy discounts are Not Insurance, and are Not Intended as a Substitute for Insurance THE DISCOUNT IS ONLY AVAILABLE AT PARTICIPATING PHARMACIES 2023 All Rights Reserved | Rx.com®